Profile of:

Nigil Haroon


Dr. Nigil Haroon, is the Head of the Division of Rheumatology for University Health Network/Sinai Health and the Co-Director of the spondylitis program at the University Health Network. He is an associate professor of medicine and rheumatology at the University of Toronto and Senior Scientist at the Krembil Research Institute and the Schroeder Arthritis Institute, a state of the art research facility in Toronto.

Full name: Nigil Haroon

Current country: Canada

Membership level: Full

Type of membership: Member

Number of publications: 37

Advances in axial spondyloarthritis: Learning from the leaders (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37985319/

Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37792508/

Prostaglandin E2/EP4 axis is upregulated in Spondyloarthritis and contributes to radiographic progression (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37075950/

Determination of Relative Weightings for Sacroiliac Joint Pathologies in the OMERACT Juvenile Arthritis Magnetic Resonance Imaging Sacroiliac Joint Score (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37048812/

ERAP1 and the return of the UPR in ankylosing spondylitis (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/36725927/

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials (2023)
https://pubmed.ncbi.nlm.nih.gov/36649967/

Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/36455954/

Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis (2023)
https://pubmed.ncbi.nlm.nih.gov/35973805/

Motivators, Barriers, and Opportunity for E-Health to Encourage Physical Activity in Axial Spondyloarthritis: A Qualitative Descriptive Study (2022)
https://pubmed.ncbi.nlm.nih.gov/34928533/

Nonspecific Low Back Pain (2022)
https://pubmed.ncbi.nlm.nih.gov/35921469/

Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35833532/

Instrument selection for the ASAS core outcome set for axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35680390/

Tender to touch-Prevalence and impact of concomitant fibromyalgia and enthesitis in spondyloarthritis: An ancillary analysis of the ASAS PerSpA study (2022)
https://pubmed.ncbi.nlm.nih.gov/35636706/

COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls (2022)
https://pubmed.ncbi.nlm.nih.gov/35105713/

Motivators, Barriers, and Opportunity for E-Health to Encourage Physical Activity in Axial Spondyloarthritis: A Qualitative Descriptive Study (2022)
https://pubmed.ncbi.nlm.nih.gov/34928533/

Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches (2022)
https://pubmed.ncbi.nlm.nih.gov/34918137/

Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing (2022)
https://pubmed.ncbi.nlm.nih.gov/34486829/

Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing (2022)
https://pubmed.ncbi.nlm.nih.gov/34486829/

Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34268914/

Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease (2021)
https://pubmed.ncbi.nlm.nih.gov/34669443/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

The gut-enthesis axis and the pathogenesis of Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/35850909/

Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease (2021)
https://pubmed.ncbi.nlm.nih.gov/34669443/

Reliability of the Preliminary OMERACT Juvenile Idiopathic Arthritis MRI Score (OMERACT JAMRIS-SIJ) (2021)
https://pubmed.ncbi.nlm.nih.gov/34640579/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33893896/

Recent advances in spondyloarthritis: positive developments in the seronegative domain (2021)
https://pubmed.ncbi.nlm.nih.gov/33763750/

Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33774593/

Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33532928/

COVID-19: What Do Rheumatologists Need to Know? (2021)
https://pubmed.ncbi.nlm.nih.gov/33403528/

Acute mental health service use is increased in rheumatoid arthritis and ankylosing spondylitis: a population-based cohort study (2020)
https://pubmed.ncbi.nlm.nih.gov/32550868/

The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study (2020)
https://pubmed.ncbi.nlm.nih.gov/32084192/

Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis (2020)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/32419337/

Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic (2020)
https://pubmed.ncbi.nlm.nih.gov/32893508/

Acute mental health service use is increased in rheumatoid arthritis and ankylosing spondylitis: a population-based cohort study (2020)
https://pubmed.ncbi.nlm.nih.gov/32550868/

Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32419337/

Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32419337/